Related by context. All words. (Click for frequent words.) 72 molecular imaging radiopharmaceutical 72 Generx TM 71 intravenous acetaminophen 70 targeted radiotherapeutic 70 Zemiva TM 70 PDX pralatrexate 69 Personalized Immunotherapy 69 Excellagen 69 Auxilium transmucosal film 68 CA9 SCAN 68 Augment TM 68 overactive bladder AA# 68 TOCOSOL Camptothecin 68 Solazed TM 67 radiation sensitizer 67 acetonide FA 67 EP #R 67 CB2 selective receptor agonist 67 Factor VIIa 67 topically applied SEPA 67 OvaRex R 67 Initiates Enrollment 67 GEM OS2 67 polysaccharide polymer 67 Perflubutane Polymer Microspheres 67 histamine dihydrochloride 67 Vascular Wrap TM 66 delivers fluocinolone acetonide FA 66 Anturol ® 66 intranasal formulation 66 Cleviprex TM clevidipine 66 Excellarate 66 Dendreon investigational 66 Cannabinor 66 Polymer Microspheres 66 Trofex 66 Injectable Suspension 66 PANVAC VF 66 Augment ™ 66 Alfacell proprietary ribonuclease 66 OvaRex ® MAb 66 IMPDH inhibitor 66 NeuroSTAT ® 66 Angiocept 66 Solazed 66 Xcytrin R 66 thetreatment 66 Azedra TM 66 SinuNase ™ 66 proprietary HuCNS SC 66 IAP inhibitor 66 rALLy clinical trial 66 Iluvien ® 65 refractory chronic lymphocytic 65 ruxolitinib 65 factor VIIa 65 PrevOnco 65 dermaPACE TM 65 Collategene 65 HuMax TAC 65 Neo Urinary Conduit 65 FOLOTYN ® 65 Troxatyl 65 SinuNase TM 65 PORxin TM 65 hypoxia activated prodrug 65 Proxinium TM 65 IV Busulfex 65 Zemiva ™ 65 Panzem R 65 muscarinic receptor agonist 65 thrombin component 65 Generx ® 65 candidate Zemiva TM 65 therapeutic monoclonal antibody 65 CRMD# 65 Aviptadil 64 Onconase 64 PHX# 64 acyclovir Lauriad R 64 M# rationally 64 ATPace TM 64 PNP inhibitor 64 OMAPRO ™ 64 zolpidem tartrate sublingual tablet 64 novel emulsion formulation 64 ALTROPANE R 64 IRX 2 64 AzaSite Plus 64 Panzem NCD 64 candidate deforolimus 64 Adenoscan R 64 compound ISA# 64 UPLYSO 64 PDE4 inhibitor 64 Serostim ® 64 Phase #b/#a clinical 64 personalized immunotherapy 64 LibiGel ® 64 Onalta ™ 64 Myocet 64 XP# XP# 64 Cloretazine ® 64 mitogen activated ERK kinase 64 successfully commercialize Iluvien 64 include Phenoptin TM 64 NP2 Enkephalin 64 romidepsin novel 64 ILUVIEN ® 64 candidate TNFerade biologic 64 humanised monoclonal antibody 64 Cardium Therapeutics TM 64 IV acetaminophen 64 Oral NKTR 64 HepaSphere 64 THR beta agonist 64 Panzem R NCD 64 ocular formulation 64 ospemifene 64 Manja Bouman CEO 64 Valtropin 64 Prednisporin TM 64 Cardio Vascu Grow 64 Biologic License Application BLA 64 investigational antiplatelet agent 64 HDL Selective Delipidation 64 BiovaxID TM 64 Spiegelmer ® 64 Zybrestat 64 tezampanel NGX# 64 Soliris TM eculizumab 64 RhuDex ® 64 aerosolized AAT 64 novel L DOS# 64 TRIOLEX HE# APOPTONE HE# 64 Zenvia ™ 64 Civacir 64 ionotropic glutamate receptor antagonists 64 rxRNA 64 investigational therapies 63 IMA# 63 Combidex 63 Initiate Clinical Trial 63 Phase 1b clinical trials 63 Cloretazine 63 phase IIb clinical 63 intravenous recombinant 63 Pyridorin 63 Cellegesic 63 proprietary intravenous formulation 63 IMiDs ® compound 63 IV APAP 63 TRO# 63 Squalamine 63 NV1FGF 63 Corgentin 63 BrachySil TM 63 PSN# [001] 63 oral talactoferrin 63 hoFH 63 lintuzumab SGN 63 including eniluracil ADH 63 drug ISA# 63 mertansine 63 Iluvien TM 63 Archexin 63 Annamycin 63 ELACYT 63 MOZOBIL 63 Opterone R 63 SNT MC# 63 Trofex TM 63 HepeX B 63 AAG geldanamycin analog 63 liposomal formulation 63 OMP #R# 63 personalized dendritic 63 vinca alkaloid 63 Omigard 63 Phase IIb clinical trials 63 Aplidin 63 DNA methylation biomarkers 63 Matrix Phase 2b 63 ASONEP TM 63 SPL# Gel vaginal microbicide 63 Vicinium TM 63 Initiates Clinical 63 R sorafenib tablets 63 Linjeta TM 63 oxypurinol 63 Anturol TM 63 valtorcitabine 63 bucindolol hydrochloride 63 Onalta 63 vapreotide acetate 63 TPI ASM8 63 oral prodrug 63 catheter occlusion 63 candidates Azedra TM 63 Neo Kidney Augment 63 sitaxsentan 63 BEMA Granisetron 63 orally inhaled migraine 63 investigational humanized monoclonal antibody 63 BrachySil 63 CINQUIL 63 oxybutynin ATD TM 63 ZEVALIN ® 63 MGN# 63 ARC# [002] 63 Pegloticase 63 reslizumab 63 PEGylated anti 63 Sphingomab TM 63 TBC# 63 human C1 inhibitor 63 Dyloject TM 63 GEM #S 63 2 methoxyestradiol 63 RhuDex TM 62 DURIN TM 62 YONDELIS 62 fibrin derived 62 Surgical Sealant 62 CYT# vascular disrupting 62 hyaluronidase enzyme 62 INTEGRILIN ® 62 dasatinib Sprycel ® 62 intravenous AAT 62 Oasmia 62 Excellagen TM 62 MKC# MKC# PP 62 novel oral anticoagulant 62 phase IIa clinical 62 GVAX ® 62 LEVADEX ™ 62 Luteinizing Hormone Releasing Hormone 62 faropenem medoxomil 62 kidney urologic 62 radiotherapeutic 62 HDL Mimetic Peptide 62 MyVax ® 62 BEMA TM Fentanyl 62 PORxin 62 wilate ® 62 ATL# [002] 62 oral beclomethasone dipropionate 62 treat chronic sinusitis 62 Kuvan TM sapropterin 62 orally administered inhibitor 62 personalized cellular immunotherapy 62 DPX Survivac 62 non porcine pancreatic 62 Davanat 62 zileuton injection 62 Vascular Disrupting Agent 62 ALGRX 62 Initiates Phase II 62 methylnaltrexone bromide 62 Relivar 62 trial evaluating PRX# 62 Xanafide 62 metastatic carcinoid 62 dihydrochloride 62 MAXY VII 62 Phase Ib study 62 Nanobody 62 elacytarabine 62 investigational pharmacologically unique 62 candidate REP# 62 inhaled liposomal ciprofloxacin 62 R Saizen R 62 generation purine nucleoside 62 ATIR 62 Vidaza R 62 CONBRIZA 62 Fx #A 62 Maxy G# 62 diagnostic radiopharmaceutical 62 outlicensed 62 Octreolin 62 pipeline GlycoPEG GCSF 62 ELADUR TM 62 Icatibant 62 efaproxiral 62 Neovasc Reducer 62 Celator 62 vinorelbine tartrate 62 SURFAXIN r 62 Premarket Approval Application 62 Safinamide 62 oncolytic virus therapies 62 EGS# 62 OMNARIS HFA 62 targets Galectin receptors 62 TransVax tm 62 novel VDA molecule 62 phase III isavuconazole 62 Cx# [002] 62 antiangiogenic agent 62 TLR8 agonist 62 cetuximab Erbitux R 62 Vascugel 62 topical gel containing 62 EVIZON TM squalamine lactate 62 Zorbtive TM 62 Chemokine Therapeutics 62 motexafin gadolinium Injection 62 immunological diseases 62 Campath ® 62 Synavive ™ 62 Urocidin 62 fusion enhancers 62 EVIZON TM 62 DOS# 62 thalidomide Thalomid 62 Nanobody R 62 PrevOnco ™ 62 tafamidis 62 defensin mimetic antibiotic 62 Cotavance 62 Augment Injectable 62 PLK1 SNALP 62 AQ4N 62 MAGE A3 ASCI 62 active cellular immunotherapy 62 Kamada AAT 62 Ceplene TM 62 Mepact 62 Resten NG 62 Shigamabs R 62 beta 1a 62 Novolimus 62 Excellarate TM 62 theranostic 62 Q#IR 62 sargramostim 62 selective androgen receptor modulator 62 Trofex ™ 62 oral ridaforolimus 62 topical antifungal 62 Zingo TM 62 Surfaxin LS 62 receptor tyrosine kinase inhibitor 62 KRYSTEXXA TM pegloticase 62 TAXUS Element Paclitaxel Eluting 62 omacetaxine mepesuccinate 61 Locked Nucleic Acid 61 Evoltra ® 61 Urocidin TM 61 commercialize CorMedix drug 61 Crofelemer budesonide foam 61 Solazed ™ 61 Silodosin 61 selective A2A adenosine receptor 61 XL# anticancer compounds 61 Anidulafungin 61 vascular disrupting agents 61 metastatic malignant 61 isoform selective 61 TELINTRA R 61 Intermezzo ® zolpidem tartrate 61 alemtuzumab MS 61 sterile lidocaine patch 61 BN# [004] 61 R vitespen 61 HepeX B TM 61 GTC recombinant human 61 VitiGam 61 Ketotransdel 61 Epigenomics proprietary 61 ASONEP ™ 61 herpetic keratitis 61 TLR9 agonist 61 PGL# 61 Marqibo TM 61 Nektar proprietary 61 XYOTAX TM 61 alvespimycin 61 Azedra ™ 61 Nanobody ® 61 indibulin 61 PI3K/Akt pathway inhibitor 61 SEPET TM 61 CINTREDEKIN BESUDOTOX 61 multicenter Phase II 61 TOCOSOL R 61 pain palliation 61 aldehyde dehydrogenase ALDH2 deficiency 61 Lixivaptan 61 Veronate 61 Tarmogen 61 LEUKINE 61 sapropterin dihydrochloride Phase 61 LHRH antagonist 61 SILENOR 61 EVIZON ™ 61 Novartis NVS Snapshot Report 61 Occlusin TM 61 targeted antifolate 61 histone deacetylase HDAC inhibitor 61 DXL# 61 Ereska 61 Hsp# Inhibitor 61 FRDA 61 HepaGam B 61 ARIKACE ™ 61 XmAb ™ 61 Liprostin 61 Exelixis compounds 61 Progenta TM 61 Alzhemed TM 61 selective immunoproteasome inhibitor 61 ESBA# 61 SMT C# 61 Panzem 61 metaglidasen 61 Triapine R 61 STEDESA 61 SPRYCEL ® 61 GTC recombinant form 61 Nebido 61 Achieves Primary Endpoint 61 Vidaza azacitidine 61 drug GLPG# 61 inhaled formulation 61 candidate Gencaro TM 61 paclitaxel poliglumex 61 novel histone deacetylase 61 fosbretabulin 61 Oracea TM 61 BRILINTA 61 BLA filing 61 NEUGENE antisense 61 Duromist ™ 61 Pivotal Phase III 61 therapeutic peptide 61 demonstrated antitumor activity 61 Cloretazine R 61 TKM ApoB 61 OMP #M# 61 ORTHOVISC mini 61 Hematide ™ peginesatide 61 Sudhir Agrawal D.Phil 61 Fludara ® 61 Soliris eculizumab 61 include PLX IBD 61 Exherin TM 61 MYDICAR ® 61 elotuzumab 61 TOCOSOL 61 depsipeptide 61 Combo Stent 61 Vidaza ® 61 Proellex TM 61 Vivecon 61 MedPulser ® 61 Prodarsan R 61 Lymphoseek ® 61 Emezine 61 tiapamil 61 NeoLipid R 61 PROVENGE sipuleucel T 61 MyVax R 61 REG2 Regado 61 Tarceva TM 61 DNA intercalator 61 KL4 Surfactant 61 dihydrochloride Phase 3 61 INxin 61 humanized therapeutic 61 pharmacokinetic equivalence 61 ALN PCS 61 drug GAP #B# 61 TELINTRA 61 VIAject R 61 oral salmon calcitonin 61 Ophena TM 61 lead molecular radiotherapeutic 61 EOquin 61 phase IIb III 61 KRN# 61 LymphoStat B TM 61 SNS# T 61 rasagiline tablets 61 Androxal ® 61 systemic immunosuppressive drugs 61 Pruvel 61 Rhucin ® recombinant 61 EcoNail TM 61 midstage clinical trials 61 poly ethylene glycol PEG 61 Aganocide 61 Phase 2a clinical trials 61 clevidipine 61 NuroPro R 61 Locteron ® 61 selective estrogen receptor modulator 61 Cinryze ™ 61 Cinryze TM C1 inhibitor 61 Inhaled nitric oxide 61 candidate XP# 61 PEGylated interferon 61 torezolid phosphate 61 VivaGel ™ 60 ART# 60 immunosuppressant therapies 60 proteasome inhibitor 60 G#DT 60 inhaled AAT 60 HEPLISAV TM 60 histone deacetylase HDAC 60 MAb therapy 60 volociximab 60 PROSTASCINT R 60 lumiliximab 60 ViaCyte 60 Telatinib 60 atacicept 60 potency selectivity 60 IMiDs R 60 Dual Opioid 60 nephropathic cystinosis 60 Gentamicin Surgical Implant 60 ONSOLIS TM 60 LEVADEX TM 60 MGd 60 immatics 60 midstage clinical 60 MelaFind R 60 epigenetic therapies 60 IgG1 monoclonal antibody 60 EOquin TM 60 Chemophase 60 Clolar ® 60 Clavis Pharma 60 LymphoStat B belimumab 60 lexidronam injection 60 BHT DNA 60 Submits Response 60 Targretin capsules 60 rusalatide acetate 60 myelodysplastic myeloproliferative diseases 60 CMV vaccine 60 iSONEP ™ 60 LungAlert TM 60 VALSTAR 60 OvaRex 60 Phase IIb III 60 SomatoKine 60 Fibrin Pad 60 virus HCV protease inhibitor 60 oral picoplatin 60 sunitinib Sutent 60 Panzem ® 60 Completes Patient Enrollment 60 Hepatitis C HCV 60 candidate epratuzumab 60 Aurexis 60 CEQ# 60 IL# PE#QQR 60 Anavex #-# 60 BrachySil ™ 60 GVAX R 60 JOULFERON 60 ProtAffin 60 targeting Inflammatory Bowel 60 acadesine 60 ONCASPAR 60 proprietary polysaccharide 60 Adnectin 60 DermaVir Patch 60 SUTENT ® 60 Cethrin R 60 Files IND 60 small molecule chemotherapeutic 60 PEGylation technology 60 IND Investigational New 60 treat refractory angina 60 Cotara ® 60 MP4 molecule 60 JAK inhibitor 60 GLP toxicology studies 60 CINtec R 60 BEMA Fentanyl 60 CYT# potent vascular disrupting 60 EndoTAG 60 Convivia TM 60 Troxatyl TM 60 synthetic peptide containing 60 Biopartners 60 Androxal TM 60 sorafenib Nexavar 60 PF # [002] 60 Phase #b/#a trial 60 malignant ascites 60 oral rivaroxaban 60 Tyrima 60 Memryte 60 TissuGlu 60 incyclinide 60 NPC 1C 60 MCSP respectively 60 topoisomerase II inhibitor 60 BCG refractory carcinoma 60 huC# DM4 60 pharmacokinetic PK study 60 Plenaxis TM 60 Kosan dependence 60 IMiD 60 dermatology biopharmaceutical company 60 XL# XL# 60 neuro inflammatory 60 Simulect 60 Entereg R 60 HQK 60 novel peptide 60 non nucleoside inhibitor 60 allogeneic cell 60 Veronate R 60 Bezielle 60 Amrubicin 60 immunotherapeutic vaccine 60 metastatic pancreatic 60 lorvotuzumab mertansine 60 Kuvan R 60 JAK#/JAK# inhibitor CYT# 60 Aerosurf 60 Application MAA 60 thymalfasin 60 Wafer polifeprosan 60 phase IIb trial 60 CAPHOSOL R 60 highly purified pasteurized 60 CCR9 antagonist 60 Leukine ® 60 AQUA ® 60 LungExpress Dx TM 60 Selective Electrochemical Tumor Ablation 60 pralatrexate injection folate analogue 60 Omigard TM 60 pharmacodynamic properties 60 Onalta TM 60 Fibrin MB 60 sumatriptan DosePro 60 Allovectin 7 60 Potelligent Technology 60 preclinical pharmacology 60 Ventavis ® 60 CDP# 60 TRX1 60 Evoltra TM 60 SynthRx 60 Aflibercept 60 Canvaxin TM 60 ATL# [001] 60 systemic anaplastic large 60 Curaxin 60 ADVEXIN p# therapy 60 Genasense ® oblimersen 60 Nasulin ™ 60 Elisabeth Lindner CEO 60 triphendiol 60 vosaroxin 60 AzaSite Xtra 60 intranasal insulin product 60 ENMD # 60 arsenic trioxide injection 60 bioequivalency 60 Argatroban 60 MyVax personalized immunotherapy 60 liprotamase 60 TRANSDUR ® 60 Zavesca r 60 JZP 60 triggers apoptosis programmed 60 Orally administered 60 Adentri 60 allosteric modulator 60 sapropterin dihydrochloride Tablets 60 Neulasta R 60 VANOS TM 60 HepaMate 60 biocompatible coatings 60 Begins Dosing 60 Posiphen TM 60 antibody MAb 60 Arimoclomol 60 octreotide implant 60 NADiA ProsVue 60 Chrysalin 60 orally inhaled 60 Evoltra 60 Somatuline R Autogel R 60 Tectin TM 60 MyoCell TM 60 immuno inflammatory 60 Loramyc R 60 accumulate preferentially 60 Hedgehog Pathway Inhibitor 60 BLP# Liposome Vaccine 60 Files Investigational 60 HEPLISAV ™ 60 Interferon beta 60 ThermoDox ® clinical 60 MKC# MT 60 topically administered 60 Certolizumab pegol 60 Veregen TM 60 Announces Poster Presentations 60 Tß4 60 Bendamustine 60 Opterone 60 systemically administered 60 generation rotary VAD 60 Increlex TM 60 Injectable Bone Graft 59 Nabi HB Intravenous 59 ACAPODENE TM 59 cannabinor 59 Meets Primary Endpoint 59 novel therapeutic antibodies 59 ® bortezomib 59 Voraxaze 59 NasdaqGM SPPI 59 neratinib 59 monoclonal antibody conjugated 59 interferon alpha IFN 59 RIGScan 59 leading oral taxane 59 edifoligide E2F Decoy 59 OVATURE 59 Allovectin 7 r 59 VALSTAR TM 59 ALK inhibitors 59 AN# novel 59 Daclizumab 59 relapsed leukemia 59 Initiates Clinical Trial 59 carbohydrate polymer 59 CTAP# Capsules 59 DNA demethylating agent 59 investigational pan BCR 59 selective adenosine 59 oral methylnaltrexone 59 tolevamer 59 Firazyr 59 hyperphenylalaninemia HPA due 59 TransVax TM 59 CD# CEA 59 acyclovir Lauriad ® 59 liposomal delivery 59 sodium glucose transporter 59 TM Drug Eluting 59 buccal spray 59 alvimopan 59 polycythemia vera essential thrombocythemia 59 Intravitreal injections 59 Alocrest 59 substantially excreted 59 Granted Orphan Drug 59 anticancer compound 59 trastuzumab DM1 T DM1 59 R bendamustine hydrochloride 59 Allovectin 7 R 59 faropenem 59 RenaZorb TM 59 Cintredekin Besudotox 59 Retacrit 59 osteobiologic 59 Dacogen injection 59 Phase III ADT 59 Triapine 59 diarrhea predominant irritable 59 GRN# 59 Adhesion Barrier 59 rhThrombin 59 p# inhibitor 59 Tezampanel 59 platforms GVAX 59 MoxDuo IR 59 Aloxi R 59 include GALNS N 59 Receives Orphan Drug Designation 59 Bellicum 59 REG1 59 Insegia 59 Bucindolol 59 Bone Graft 59 Azacitidine 59 seliciclib CYC# 59 EmbraceAC 59 Breast Cancer Assay 59 liver resection surgeries 59 compound AEZS 59 Targeted Chemotherapy 59 cartilage regeneration 59 SYCREST 59 darinaparsin ZIO 59 cell carcinoma RCC 59 muscarinic receptor agonists 59 INTERCEPT red 59 Zemplar Capsules 59 ALN TTR# 59 mild vasodilator 59 ADVEXIN therapy 59 QNEXA ® 59 vitreoretinal disorders 59 NeoLipid TM 59 Orphan Drug status 59 Anticalins R 59 Elafin 59 Relypsa 59 DCVax R 59 EndoTAG TM 59 Qutenza TM 59 proprietary intranasal insulin 59 Prednisporin 59 candidate AQ4N 59 Aceon 59 ganaxolone 59 #D#C# 59 bardoxolone 59 Capesaris 59 balsalazide tablet 59 Reports Preclinical Data 59 subsidiaries visit http:/www.apricusbio.com 59 sapacitabine CYC# 59 HSP# inhibitor 59 forodesine hydrochloride 59 Micromet proprietary BiTE 59 HGS# 59 Aegerion Pharmaceuticals 59 Chimigen TM 59 NexACT ® 59 biodegradable implant 59 Provenge sipuleucel T 59 macitentan 59 AFREZZA ® 59 LEP ETU 59 lucinactant 59 Raptiva ® 59 XmAb ® 59 markets HP Acthar 59 SYN# 59 treats acute lymphoblastic 59 WX UK1 59 aurora kinase 59 epoetin alpha 59 Initiates Phase III 59 Trophos 59 Zoraxel 59 essential thrombocythemia ET 59 DIFICID ™ 59 Premarket Approval PMA 59 preclinical efficacy 59 Shigamabs ® 59 CTAP# Injection 59 therefore therapeutically equivalent 59 ONCONASE R 59 HuMax 59 OncoVex 59 muco adhesive technology 59 MOVIPREP R 59 TNFerade TM 59 nasal calcitonin product 59 VitiGam TM 59 metastatic colorectal 59 TLK# 59 PDE4 modulators 59 PEGylated interferon beta 1a 59 integrin inhibitor 59 R sipuleucel T 59 OTCBB HXBM developer 59 OvaDx 59 JenaValve 59 ZYBRESTAT fosbretabulin 59 OTCBB PYTO 59 Eluting Stent 59 Phase III multicenter 59 Martin Nicklasson CEO 59 XIENCE V Everolimus Eluting 59 polymer conjugate technology 59 rifalazil 59 KNS # 59 Unit Dose Budesonide 59 CaPre TM 59 ZOLINZA 59 CG# [003] 59 therapeutic peptide PCK# 59 Phase Ib clinical 59 Combination REOLYSIN R 59 BioSTAR ® 59 lenalidomide Revlimid R 59 TNF Tumor Necrosis Factor 59 anti botulism antibody 59 HCV antiviral 59 pharmacogenomic translational research 59 IMiDs ® 59 punctal plug delivery 59 vaginally administered lidocaine 59 Solzira TM 59 Alexza Staccato 59 Acetavance TM intravenous acetaminophen 59 Lauriad ® 59 Phase #b/#a 59 Urokinase 59 NerPharMa 59 JAK2 inhibitor 59 Phase Ib clinical trials 59 oral anti arrhythmic 59 either acutely decompensated 59 Toraymyxin 59 Octreotide 59 DAVANAT 59 Initiates Phase 2b 59 Gonal f R 59 assessing T DM1 59 Peginterferon alfa 2b 59 treat male hypogonadism 59 gepirone ER 59 TRANSDUR Bupivacaine 59 Amgen Neulasta ® 59 Biolimus A9 59 Medidur ™ FA 59 KYTHERA 59 Homspera TM 59 progressive metastatic prostate 59 miRview mets 59 Granulocyte Colony Stimulating Factor 59 supplemental biologics 59 #I TM# 59 Phase III Clinical Trial 59 cancer immunotherapies 59 candidates bavituximab 59 Cutanea 59 Fodosine 59 apomorphine hydrochloride 59 Hexvix ® 59 KALBITOR ® 59 Brussels THR 59 OvaRex MAb 59 urethral bulking agent 59 Septin9 59 HuMax HepC TM 59 investigational hepatitis C 59 Microplasmin 59 HuCNS SC ® 59 TYZEKA 59 A1PI 59 Fibrillex TM 59 rALLy trial 59 Extina 59 Myolimus 59 miconazole Lauriad R 59 bortezomib Velcade 59 NB S# strontium malonate 59 relapsed multiple myeloma 59 Trobalt 59 RSR# 59 Pivotal Clinical Trial 59 concerning CombinatoRx 59 anti infective treatments 59 etanercept Enbrel 59 BiDil XR 59 TKM PLK1 59 SynCon TM DNA 59 EFAPROXYN 59 BENLYSTA ® 59 vascular disrupting agent 59 Pivotal Study 59 VITOSS 59 candidate brentuximab vedotin 59 toenail onychomycosis 58 Immunotherapeutic 58 GATTEX ® 58 oral proteasome inhibitor 58 proprietary transdermal 58 unoprostone isopropyl 58 sapropterin dihydrochloride 58 PNT# 58 Frova ® 58 chimeric monoclonal antibody 58 anti CD3 monoclonal 58 ZFP Therapeutics 58 osteogenic 58 molecular imaging radiopharmaceuticals 58 Calixa 58 Pivotal Trial 58 RhuDex R 58 acute peripheral arterial 58 Captisol enabled 58 Meritage Pharma 58 modified glutathione analog 58 5 FU leucovorin 58 BioSTAR R 58 RECOTHROM R 58 Neo Kidney Augment ™ 58 Fentanyl TAIFUN R